REFERENCES

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.

2. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017;38:2739-91.

3. Prendergast BD, Baumgartner H, Delgado V, et al. Transcatheter heart valve interventions: Where are we? Eur Heart J 2019;40:422-440.

4. Del Forno B, De Bonis M, Agricola E, et al. Mitral valve regurgitation: a disease with a wide spectrum of therapeutic options. Nat Rev Cardiol 2020;17:807-27.

5. Dal-Bianco JP, Levine RA. Anatomy of the mitral valve apparatus: role of 2D and 3D echocardiography. Cardiol Clin 2013;31:151-64.

6. Zamorano JL, González-Gómez A, Lancellotti P. Mitral valve anatomy: Implications for transcatheter mitral valve interventions. EuroIntervention 2014;10 Suppl U:U106-11.

7. Pozzoli A, Zuber M, Reisman M, Maisano F, Taramasso M. Comparative anatomy of mitral and tricuspid valve: what can the interventionlist learn from the surgeon. Front Cardiovasc Med 2018;5:80.

8. Timek TA, Green GR, Tibayan FA, et al. Aorto-mitral annular dynamics. Ann Thorac Surg 2003;76:1944-50.

9. McCarthy KP, Ring L, Rana BS. Anatomy of the mitral valve: Understanding the mitral valve complex in mitral regurgitation. Eur J Echocardiogr 2010;11:i3-9.

10. Ritchie J, Warnock JN, Yoganathan AP. Structural characterization of the chordae tendineae in native porcine mitral valves. Ann Thorac Surg 2005;80:189-97.

11. Otto CM. Clinical practice. Evaluation and management of chronic mitral regurgitation. N Engl J Med 200;345:740-6.

12. O’Gara PT, Mack MJ. Secondary mitral regurgitation. N Engl J Med 2020;383:1458-67.

13. Estévez-Loureiro R, Benito-González T, Garrote-Coloma C, et al. Percutaneous mitral repair: current and future devices. Ann Transl Med 2020;8:963.

14. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation 2021;143:e35-e71.

15. Halim J, Van den Branden B, Coussement P, Kedhi E, Van der Heyden J. Percutaneous mitral valve repair: the necessity to redefine secondary mitral regurgitation. Neth Heart J 2020;28:272-9.

16. Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014;370:23-32.

17. Kumar A, Al-khafaji J, Shariff M, Vaz IP, Adalja D, Doshi R. Percutaneous mitral valve repair for secondary mitral valve regurgitation: a systematic review and meta-analysis. Eur J Intern Med 2020;78:107-12.

18. Arnold S V. Frail elderly, the ideal patients for mitraclip. JACC Cardiovasc Interv 2017;10:1930-1.

19. Metze C, Matzik AS, Scherner M, et al. Impact of frailty on outcomes in patients undergoing percutaneous mitral valve repair. JACC Cardiovasc Interv 2017;10:1920-9.

20. Chakravarty T, Makar M, Patel D, et al. Transcatheter edge-to-edge mitral valve repair with the mitraclip G4 system. JACC Cardiovasc Interv 2020;13:2402-14.

21. Khan F, Winkel M, Ong G, et al. Percutaneous mitral edge-to-edge repair: state of the art and a glimpse to the future. Front Cardiovasc Med 2019;6:122.

22. Huded C, Kapadia S. Treatment of functional mitral regurgitation with transcatheter edge-to-edge repair. Interv Cardiol Clin 2019;8:235-43.

23. Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation 5-year results of EVEREST II. J Am Coll Cardiol 2015;66:2844-54.

24. Boekstegers P, Hausleiter J, Baldus, et al. Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 2014;103:85-96.

25. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 2018;379:2307-18.

26. Obadia J-F, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 2018;379:2297-306.

27. Sherif MA, Paranskaya L, Yuecel S, et al. Mitraclip step by step; how to simplify the procedure. Neth Heart J 2017;25:125-30.

28. Stone GW, Adams DH, Abraham WT, et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol 2015;66:308-21.

29. Benito-González T, Estévez-Loureiro R, Villablanca PA, et al. Percutaneous mitral valve repair vs. stand-alone medical therapy in patients with functional mitral regurgitation and heart failure. Cardiovasc Revasc Med 2020;21:52-60.

30. Lim DS, Kar S, Spargias K, et al. Transcatheter valve repair for patients with mitral regurgitation: 30-day results of the CLASP study. JACC Cardiovasc Interv 2019;12:1369-78.

31. Miller M, Thourani VH, Whisenant B. The Cardioband transcatheter annular reduction system. Ann Cardiothorac Surg 2018;7:741-7.

32. Feldman T, Young A. Percutaneous approaches to valve repair for mitral regurgitation. J Am Coll Cardiol 2014;63:2057-68.

33. Goode D, Dhaliwal R, Mohammadi H. Transcatheter mitral valve replacement: state of the art. Cardiovasc Eng Technol 2020;11:229-53.

34. Witte KK, Lipiecki J, Siminiak T, et al. The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation. JACC Hear Fail 2019;7:945-55.

35. Di Micco L, Peruzzo P, Colli A, et al. The neochord mitral valve repair procedure: Numerical simulation of different neochords tensioning protocols. Med Eng Phys 2019;74:121-8.

36. Randomized Trial of the Neochord^TM DS1000^TM System Versus Open Surgical Repair - Full Text View - ClinicalTrials.gov [Internet]. Available from: https://clinicaltrials.gov/ct2/show/NCT02803957. [Last accessed on 25 Nov 2020].

37. Regueiro A, Granada JF, Dagenais F, Rodés-Cabau J. Transcatheter mitral valve replacement: insights from early clinical experience and future challenges. J Am Coll Cardiol 2017;69:2175-92.

38. Sondergaard L, De Backer O, Franzen OW, et al. First-in-human case of transfemoral cardiAQ mitral valve implantation. Circ Cardiovasc Interv 2015;8:e002135.

39. Bapat V, Rajagopal V, Meduri C, et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol 2018;71:12-21.

40. Yoon SH, Whisenant BK, Bleiziffer S, et al. Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings. J Am Coll Cardiol 2017;70:1121-31.

41. NAVIGATE Transcatheter Tricuspid Valve Replacement…Early Findings-Technology and Clinical Updates. Available from: https://www.tctmd.com/slide/navigate-transcatheter-tricuspid-valve-replacement-early-findings-technology-and-clinical-0. [Last accessed on 13 Nov 2020].

42. Cheung A, Webb J, Verheye S, et al. Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol 2014;64:1814-9.

43. CardioValve: Device Attributes, Implant Procedure, and Early Results. Available from: https://www.tctmd.com/slide/cardiovalve-device-attributes-implant-procedure-and-early-results. [Last accessed on 13 Nov 2020].

44. New Technology Update: Cephea. Available from: https://www.tctmd.com/slide/new-technology-update-cephea. [Last accessed on 13 Nov 2020].

45. 4C Medical’s AltaValve: The First Human Experience. Available from: https://www.tctmd.com/slide/4c-medicals-altavalve-first-human-experience. [Last accessed on 13 Nov 2020].

46. Preston-Maher GL, Torii R, Burriesci G. A technical review of minimally invasive mitral valve replacements. Cardiovasc Eng Technol 2015;6:174-84.

47. Testa L, Popolo Rubbio A, Casenghi M, Pero G, Latib A, Bedogni F. Transcatheter mitral valve replacement in the transcatheter aortic valve replacement era. J Am Heart Assoc 2019;8:e013352.

48. Overtchouk P, Piazza N, Granada J, Soliman O, Prendergast B, Modine T. Advances in transcatheter mitral and tricuspid therapies. BMC Cardiovasc Disord 2020;20:1.

49. Yoon SH, Bleiziffer S, Latib A, et al. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement. JACC Cardiovasc Interv 2019;12:182-93.

50. Coisne A, Pontana F, Tchétché D, et al. Transcatheter mitral valve replacement: Factors associated with screening success and failure. EuroIntervention 2019;15:E983-9.

51. Vaquerizo B, Theriault-Lauzier P, Piazza N. Percutaneous transcatheter mitral valve replacement: patient-specific three-dimensional computer-based heart model and prototyping. Rev Española Cardiol 2015;68:1165-73.

52. Niikura H, Gössl M, Kshettry V, et al. Causes and clinical outcomes of patients who are ineligible for transcatheter mitral valve replacement. JACC Cardiovasc Interv 2019;12:196-204.